Results

Total Results: 7,637 records

Showing results for "therapy".

6601. Management of Infantile Hemangioma | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/products/infantile-hemangioma/clinician

6602. Appendix - Adverse Drug Events in U.S. Hospitals, 2010 Versus 2014 (pdf file)
      hcup-us.ahrq.gov/reports/statbriefs/sb234-appendix.pdf
      January 01, 2014 - effects in therapeutic use E930.4 Tetracycline group causing adverse effects in therapeutic use E930.5 … in therapeutic use E931.6 Anthelmintics causing adverse effects in therapeutic use E931.7 Antiviral … 285.3 Antineoplastic chemotherapy induced anemia 528.01 Mucositis (ulcerative) due to antineoplastic therapy … emollients, demulcents, and protectants 976.4 Poisoning by keratolytics, keratoplastics, other hair treatment … causing adverse effects in therapeutic use E946.4 Keratolytics, keratoplastics, other hair treatment

6603. Type of Drug & ADE (by drug-type) (pdf file)
      hcup-us.ahrq.gov/reports/statbriefs/sb158_appendix.pdf
      December 25, 2022 - effects in therapeutic use E930.4 Tetracycline group causing adverse effects in therapeutic use E930.5 … in therapeutic use E931.6 Anthelmintics causing adverse effects in therapeutic use E931.7 Antiviral … 285.3 Antineoplastic chemotherapy induced anemia 528.01 Mucositis (ulcerative) due to antineoplastic therapy … emollients, demulcents, and protectants 976.4 Poisoning by keratolytics, keratoplastics, other hair treatment … causing adverse effects in therapeutic use E946.4 Keratolytics, keratoplastics, other hair treatment

6604. State of the Science and Future Directions To Improve Diagnostic Safety in Older Adults (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/diagnostic/resources/issue-briefs/dx-safety-older-adults.pdf
      January 17, 2024 - have multiple chronic conditions (MCCs) and complex health and social needs.3 To ensure effective treatments … potential to lead to severe harm in about 6 million outpatients per year.4 It can lead to inappropriate treatments … A physical therapy examination later revealed atypical benign paroxysmal positional vertigo, highlighting … unnecessary prescription of antibiotics in this population and the impact of inappropriate antibiotic therapy … Pitfalls in the diagnosis and therapy of infections in elderly patients--a mini-review.

6605. AHRQ Multiple Chronic Conditions Research Summit: Speaker Biosketches | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/settings/long-term-care/resource/multichronic/summit-bios.html
      November 01, 2021 - As a certified Master Gardener, she volunteers in therapeutic horticulture programs. … Goldberg Young Investigator Award from the American Society of Clinical Pharmacology and Therapeutics … She has extensive training in evidence-based treatments, particularly for children and adolescents. … variations and the relationship between patients’ social, functional, and medical characteristics and treatment … i.e., the use of strategies to help providers scale up and spread effective practices in real-world treatment

6606. Aspirin Use to Prevent Cardiovascular Disease and Colorectal Cancer: Updated Modeling Study for the USPSTF (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/MLeu_yFpPwzcZwKG6fw5ZY
      April 26, 2022 - Screening and treatment for hypertension and dyslipidemia and use of aspirin for secondary pre- vention … AHA/ACCF secondary prevention and risk reduction therapy Clinical Review & Education US Preventive Services … Annual risk of major bleeding among persons without cardiovascular disease not receiving antiplatelet therapy … Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. … of High Blood Cholesterol in Adults (Adult Treatment Panel III).

6607. Mental-Illness-Heart Executive (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/related_files/mental-illness-heart_executive.pdf
      April 01, 2013 - in primary care settings, most individuals with SMI receive mental health treatment in specialized … No studies evaluated orlistat, an FDA-approved medication for the treatment of obesity that is also … There were few studies of other smoking cessation treatments (including nicotine replacement therapy … ) and no evidence of benefit for these other treatments. … replacement therapy is effective in non-SMI populations but has not been adequately studied in patients

6608. Slide 1
      effectivehealthcare.ahrq.gov/sites/default/files/study-design-considerations-chapter-2.pptx
      January 01, 2013 - Confounding by indication leads to higher propensity for treatment or more intensive treatment in those … Multiple outcomes can be assessed from given treatments. … for covariates that may be affected by prior treatments. … The causal interpretation changes from the effect of treatment versus no treatment on the outcome to … A meta-analysis of the association between adherence to drug therapy and mortality.

6609. Availability of Outpatient Maternal Fetal Medicine and Specialty Care for Women with High-Risk Pregnancies (pdf file)
      www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/availability/chipra-133-fullreport.pdf
      January 01, 2019 - multidisciplinary management (Galbally, Roberts, Buist, 2010; Gentile, 2010), individualized pharmacological therapy … Maternal and fetal implications of anticonvulsive therapy during pregnancy. … Antipsychotic therapy during early and late pregnancy. A systematic review. … Substance abuse treatment linked with prenatal visits improves perinatal outcomes: A new standard. … Treatment of valvular heart disease during pregnancy for improving maternal and neonatal outcome.

6610. Prioritization and Selection of Harms for Inclusion in Systematic Reviews (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/ehc-presentation-selection-harms-systematic-reviews.pdf
      February 01, 2018 - identify and prioritize potential harms • Identify the types and number of harms to include for treatments … Identify the types and number of harms to include for treatments and diagnostic tests. … Challenges in systematic reviews that assess treatment harms. … It may be difficult to distinguish harms from failed treatments (e.g., myocardial infarction in patients … on statin therapy); whether an event is classified as a benefit or harm may depend on the intended effect

6611. Screening for Visual Impairment in Children Younger than Age 5 Years: An Update of the Evidence from Randomized Controlled Trials, 1999–2003 (pdf file)
      www.uspreventiveservicestaskforce.org/home/getfilebytoken/RkowkNFvCYh9hMnEBcCkGh
      May 01, 2004 - lead to better treatment outcomes (primary prevention)? … Both treatments were well-tolerated. … atropine or other intereye acuity cycloplegics; more difference ≥ 3 LogMAR than 2 mos of lines amblyopia therapy … patients (9%), respectively (P < 0.001); this difference did not persist with further follow- up; both treatments … for Most children in treatment show The Amblyopia Treatment Study, a good-quality head- amblyopia effective

6612. Assessing the Risk of Bias of Individual Studies in Systematic Reviews of Health Care Interventions (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-bias-individual-studies_methods.pdf
      March 01, 2012 - , physician-directed selection of treatments, or association of treatment assignments with demographic … Harms are defined as the “totality of possible adverse consequences of any intervention, therapy or … For example, consider an RCT evaluating the outcomes of a new drug therapy relative to those of a placebo … Who decided seriousness, severity, and causal relation with the treatments? … Aid to the evaluation of therapeutic studies. Pediatrics 1989 Nov;84(5):815-27.

6613. Archived: Final Evidence Summary: Syphilis Infection in Pregnancy: Screening | United States Preventive Services Taskforce
      www.uspreventiveservicestaskforce.org/uspstf/document/final-evidence-summary94/syphilis-infection-in-pregnancy-screening-2009
      May 15, 2009 - , 3% received delayed treatment, 3% declined treatment, and 2% were lost to follow-up. … syphilis before or during pregnancy, including 22.6% who did not have an adequate serologic response to therapy … Compared treatments or supplements used by at least 0.5% of pregnant women during critical periods who … failed, 5 to women who declined treatment, and 7 to women who received late treatments. … Previous reports of 1-5 anaphylactic reactions per 100,000 treatments.

6614. Tool 3 Continued | Agency for Healthcare Research and Quality
      www.ahrq.gov/es/patient-safety/settings/hospital/red/toolkit/redtool3a.html
      March 01, 2025 - Ask if the patient uses or plans to use any other types of treatments along with the medicines, such … Is there a reason we shouldn't add this to the treatment plan?" … Thus, exploring health beliefs can assist in treatment plan adherence. … For example, diet can affect anticoagulation therapy, glucose control, and response to congestive heart … failure treatment.

6615. Tool 3 Continued | Agency for Healthcare Research and Quality
      www.ahrq.gov/patient-safety/settings/hospital/red/toolkit/redtool3a.html
      March 01, 2025 - Ask if the patient uses or plans to use any other types of treatments along with the medicines, such … Is there a reason we shouldn't add this to the treatment plan?" … Thus, exploring health beliefs can assist in treatment plan adherence. … For example, diet can affect anticoagulation therapy, glucose control, and response to congestive heart … failure treatment.

6616. Acute Lymphocytic Leukemia | Effective Health Care (EHC) Program
      effectivehealthcare.ahrq.gov/health-topics/acute-lymphocytic-leukemia

6617. Nonopioid Pharmacologic Treatments for Chronic Pain: Evidence Summary (pdf file)
      effectivehealthcare.ahrq.gov/sites/default/files/nonopioid-chronic-pain-summary.pdf
      April 01, 2020 - , but less applicable to selecting among nonopioid treatments. … also reviewed evidence that may help inform decisions regarding prioritization of nonopioid drug therapies … by clinicians and patients when selecting therapy. … Opioid Treatments for Chronic Pain: A Systematic Review. … Noninvasive Nonpharmacologic Treatments for Chronic Pain: An Update.

6618. 2003 HCUP Nationwide Inpatient Sample (NIS) Comparison Report
      hcup-us.ahrq.gov/db/nation/nis/reports/2003niscomparisonrpt.jsp
      May 01, 2016 - The estimated NIS rate was more than twice as high for "physical therapy." … The relationship between hospital size and treatment patterns is an example. … 555 (59) 531 (28) 2.49 (0.06) 2.47 (0.20) 0.00 (0.00) 0.01** (0.00) 231: Other therapeutic … 1.45 (0.04) 1.52 5.61 (0.18) 5.36 4.01 (0.12) 3.78 $21,475 (740) $20,244 146: Treatment … 0.02) 1.15* 5.91 (0.08) 6.10* 1.37 (0.06) 1.41 $19,665 (511) $20,030 231: Other therapeutic

6619. Slide 1 (ppt file)
      www.ahrq.gov/sites/default/files/wysiwyg/professionals/clinicians-providers/guidelines-recommendations/tobacco/clinicians/presentations/2008update-overview/slide.ppt
      May 07, 2008 - Its emphasis is on treatment in a health care setting. … No other mono-therapy, medicine combination or altered duration which could be tested were found to be … However, effective treatments exist that can significantly increase rates of long-term abstinence. … Tobacco dependence treatments are effective across a broad range of populations. … Providing coverage for these treatments increases quit rates.

6620. Human Factors Considerations in the Design and Implementation of Telemedicine Integrated Ambulance-Based Environments for Stroke Care - Final Report (pdf file)
      digital.ahrq.gov/sites/default/files/docs/citation/r03hs026809-madathil-final-report-2022.pdf
      January 01, 2022 - Thus, the earlier patients receive treatment, the more likely they are to have improved clinical outcomes … This can decrease time between first provider contact and definitive therapy, as specialists can rapidly … identify and triage stroke patients to decrease the time between first provider contact and definitive therapy … referred to as a tissue plasminogen activator (tPA).1 This treatment has multiple conditions and … Shortening time to stroke treatment using ambulance telemedicine: TeleBAT.